Key statistics
As of last trade Novavax Inc (NVVX.A:GER) traded at 12.18, -25.22% below its 52-week high of 16.28, set on Jul 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 12.34 |
---|---|
High | 12.38 |
Low | 12.18 |
Bid | 12.39 |
Offer | 12.44 |
Previous close | 12.43 |
Average volume | 4.96k |
---|---|
Shares outstanding | 160.09m |
Free float | 153.08m |
P/E (TTM) | -- |
Market cap | 2.18bn USD |
EPS (TTM) | -2.76 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 14:41 BST.
More ▼
Press releases
- Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development
- Novavax 2024-2025 Formula COVID-19 Vaccine Available at Major Pharmacies Across the U.S.
- Novavax to Participate in Upcoming September Conferences
- Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.
- Novavax Reports Second Quarter 2024 Financial Results and Operational Highlights
- Novavax to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Operational Highlights on August 8, 2024
More ▼